{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:22:33Z","timestamp":1792819353299,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm that manifests histologically as a lobular proliferation of stellate to spindle-shaped cells in a myxoid background, exhibiting morphologic overlap with other cartilaginous and myxoid tumors of bone. CMF is characterized by recurrent genetic rearrangements that place the glutamate receptor gene <jats:italic toggle=\"yes\">GRM1<\/jats:italic> under the regulatory control of a constitutively active promoter, leading to increased gene expression. Here, we explore the diagnostic utility of GRM1 immunohistochemistry as a surrogate marker for <jats:italic toggle=\"yes\">GRM1<\/jats:italic> rearrangement using a commercially available monoclonal antibody in a study of 230 tumors, including 30 CMF cases represented by 35 specimens. GRM1 was positive by immunohistochemistry in 97% of CMF specimens (34\/35), exhibiting moderate to strong staining in more than 50% of neoplastic cells; staining was diffuse (&gt;95% of cells) in 25 specimens (71%). Among the 9 CMF specimens with documented exposure to acid decalcification, 4 (44%) exhibited diffuse immunoreactivity (&gt;95%) for GRM1, whereas all 15 CMF specimens (100%) with lack of exposure to decalcification reagents were diffusely immunoreactive (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.003). High <jats:italic toggle=\"yes\">GRM1<\/jats:italic> expression at the RNA level was previously observed by quantitative reverse transcription polymerase chain reaction in 9 CMF cases that were also positive by immunohistochemistry; low <jats:italic toggle=\"yes\">GRM1<\/jats:italic> expression was observed by quantitative reverse transcription polymerase chain reaction in the single case of CMF that was negative by immunohistochemistry. GRM1 immunohistochemistry was negative (&lt;5%) in histologic mimics of CMF, including conventional chondrosarcoma, enchondroma, chondroblastoma, clear cell chondrosarcoma, giant cell tumor of the bone, fibrous dysplasia, chondroblastic osteosarcoma, myoepithelial tumor, primary aneurysmal bone cyst, brown tumor, phosphaturic mesenchymal tumor, CMF-like osteosarcoma, and extraskeletal myxoid chondrosarcoma. These results indicate that GRM1 immunohistochemistry may have utility in distinguishing CMF from its histologic mimics.<\/jats:p>","DOI":"10.1097\/pas.0000000000001921","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:09:22Z","timestamp":1654146562000},"page":"1407-1414","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics"],"prefix":"10.1097","volume":"46","author":[{"given":"Angus M.S.","family":"Toland","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Wai","family":"Lam","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushama","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Kunder","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy A.","family":"Kerr","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoly","family":"Szuhai","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith V.M.G.","family":"Bov\u00e9e","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Charville","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"R2-20250608","first-page":"514","article-title":"Chondromyxoid fibroma: a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation","volume":"12","author":"Nielsen","year":"1999","journal-title":"Mod Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0046-8177(98)90058-2","article-title":"Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases","volume":"29","author":"Wu","year":"1998","journal-title":"Hum Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.humpath.2009.07.014","article-title":"Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone","volume":"41","author":"Konishi","year":"2010","journal-title":"Hum Pathol"},{"key":"R5-20250608","first-page":"664","article-title":"Chondromyxoid fibroma: report of six cases with immunohistochemical studies","volume":"3","author":"Bleiweiss","year":"1990","journal-title":"Mod Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jclinpath-2014-202601","article-title":"ERG expression in chondrogenic bone and soft tissue tumours","volume":"68","author":"Shon","year":"2015","journal-title":"J Clin Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2353\/ajpath.2010.091277","article-title":"Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes","volume":"177","author":"Romeo","year":"2010","journal-title":"Am J Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng.2927","article-title":"GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma","volume":"46","author":"Nord","year":"2014","journal-title":"Nat Genet"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"eaam8419","DOI":"10.1126\/science.aam8419","article-title":"Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors","volume":"361","author":"Anderson","year":"2018","journal-title":"Science"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/his.12713","article-title":"CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma","volume":"67","author":"Shibuya","year":"2015","journal-title":"Histopathology"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAT.0000000000000122","article-title":"STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics","volume":"46","author":"Cheah","year":"2014","journal-title":"Pathology"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PAS.0000000000000137","article-title":"STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors","volume":"38","author":"Yoshida","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/modpathol.2010.124","article-title":"Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics","volume":"23","author":"Yoshida","year":"2010","journal-title":"Mod Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0b013e31824230d0","article-title":"MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype","volume":"36","author":"Yoshida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/modpathol.2010.229","article-title":"MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone","volume":"24","author":"Dujardin","year":"2011","journal-title":"Mod Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000001355","article-title":"FOS expression in osteoid osteoma and osteoblastoma: a valuable ancillary diagnostic tool","volume":"43","author":"Amary","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41467-018-04530-z","article-title":"Recurrent rearrangements of FOS and FOSB define osteoblastoma","volume":"9","author":"Fittall","year":"2018","journal-title":"Nat Commun"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-019-02684-9","article-title":"Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma","volume":"476","author":"Lam","year":"2020","journal-title":"Virchows Arch"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PAS.0000000000001555","article-title":"Immunohistochemical characterization of giant cell tumor of bone treated with denosumab: support for osteoblastic differentiation","volume":"45","author":"Kerr","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.22000","article-title":"Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy","volume":"126","author":"Schaefer","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cncr.22798","article-title":"The role of noncartilage-specific molecules in differentiation of cartilaginous tumors","volume":"110","author":"Romeo","year":"2007","journal-title":"Cancer"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2559.1996.d01-512.x","article-title":"Chondromyxoid fibroma-like osteosarcoma: a distinct variant of low-grade osteosarcoma","volume":"29","author":"Chow","year":"1996","journal-title":"Histopathology"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"2632010X211057555","DOI":"10.1177\/2632010X211057555","article-title":"Chondromyxoid fibroma-like osteosarcoma in a 13 years old girl: a report of a new case","volume":"14","author":"Derqaoui","year":"2021","journal-title":"Clin Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12891-020-3063-5","article-title":"Chondromyxoid fibroma-like osteosarcoma: a case series and literature review","volume":"21","author":"Zhong","year":"2020","journal-title":"BMC Musculoskelet Disord"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:02:59Z","timestamp":1749416579000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001921","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}